- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/755 - Factors VIII
Patent holdings for IPC class C07K 14/755
Total number of patents in this class: 815
10-year publication summary
|
68
|
84
|
65
|
88
|
63
|
53
|
51
|
49
|
39
|
14
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bioverativ Therapeutics Inc. | 210 |
83 |
| Takeda Pharmaceutical Company Limited | 2702 |
57 |
| Octapharma AG | 204 |
28 |
| Novo Nordisk A/S | 2251 |
21 |
| The Children's Hospital of Philadelphia | 766 |
17 |
| CSL Behring GmbH | 343 |
16 |
| Baxalta Incorporated | 295 |
15 |
| CSL Limited | 253 |
15 |
| St. Jude Children's Research Hospital | 243 |
15 |
| Bayer HealthCare LLC | 1360 |
14 |
| The Trustees of the University of Pennsylvania | 4268 |
14 |
| CSL Behring Lengnau AG | 125 |
14 |
| Baxalta GmbH | 104 |
13 |
| Emory University | 1606 |
13 |
| Baxter International Inc. | 2426 |
11 |
| Georgia Tech Research Corporation | 2666 |
11 |
| BioMarin Pharmaceutical Inc. | 370 |
11 |
| UCL Business Ltd | 572 |
11 |
| Baxter Healthcare S.A. | 1829 |
10 |
| Biogen MA Inc. | 884 |
8 |
| Other owners | 418 |